Blunted blood pressure response to central sympathoinhibition in normotensive blacks: Pressure maintenance in blacks: Increased importance of nonsympathetic factors in blood pressure maintenance in blacks

Hypertension

Volumn 30, Issue 2, 1997, Pages 157-162

  Lang, Chim C ^a   Stein, C Michael ^a   He, Huai B ^a   Belas, Frank J ^a   Blair, Ian A ^a   Wood, Margaret ^a   Wood, Alastair J J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic; Alpha; Blacks; Clonidine; Norepinephrine; Receptors

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; NORADRENALIN;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CAUCASIAN; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEGRO; NORADRENALIN BLOOD LEVEL; NORADRENALIN RELEASE; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; SYMPATHETIC BLOCKING; SYMPATHETIC TONE;

EID: 0030752364     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.2.157     Document Type: Article

References (45)

1. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differences in the impact of hypertension in the United States. Arch Intern Med. 1989;149:78-88.
2. Rowland M, Roberts J. Blood Pressure Levels and Hypertension in Persons Ages 6-74 Years: United States, 1976-80. Hyattsville, Md: US Department of Health and Human Services, 1982. National Center for Health Statistics. Advance data from Vital and Health Statistics, No. 84. DHSS publication (PHS) 82-1250.
3. National Center for Health Statistics. Vital Statistics of the United States, 1977. Volume II. Mortality. Part B. Washington, DC: Government Printing Office, 1980. DHSS publication (PHS) 80-112.
4. Gillum RF. Pathophysiology of hypertension in blacks and whites. Hypertension. 1979;1:468-475.
5. Faulkner B. Differences in blacks and whites with essential hypertension: biochemistry and endocrine. Hypertension. 1990;15: 681-686.
6. Kaplan NM. Ethnic aspects of hypertension. Lancet. 1994;344: 450-452.
7. Voors AM, Webber LS, Berensen GS. Racial contrasts in cardiovascular response tests for children from a total community. Hypertension. 1980;2:686-694.
8. Murphy JK, Alpert BS, Moes DM, Somes GW. Race and cardiovascular reactivity: a neglected relationship. Hypertension. 1986;8: 1075-1083.
9. Thomas J, Semenya K, Thomas CB, Thomas DJ, Neser WB, Pearson TA, Gillum RF. Precursors of hypertension in black compared to white medical students. J Chronic Dis. 1987;40: 721-727.
10. Anderson NB, Lane JD, Muranaka M, Williams RB Jr. Racial differences in blood pressure and forearm vascular responses to the cold face stimulus. Psychosom Med. 1988;50:57-63.
11. Anderson NB, Myers HF, Pickering T, Jackson JS. Hypertension in blacks: psychosocial and biological perspectives. J Hypertens. 1989; 7:161-172.
12. Falkner B. Is there a black hypertension? Hypertension. 1987;10: 551-554.
13. Light KC, Obrist PA, Sherwood A, James SA, Strogatz DZ. Effects of race and marginally elevated blood pressure on responses to stress. Hypertension. 1987;10:555-563.
14. Calhoun DA, Mutinga ML, Collins AS, Wyss JM, Oparil S. Normotensive blacks have heightened sympathetic response to cold pressor test. Hypertension. 1993;22:801-805.
15. Chalmers JP. Brain amines and models of experimental hypertension. Circ Res. 1975;36:469-480.
16. Korner PI, Badoer E, Head G. Cardiovascular role of the major noradrenergic cell groups in the rabbit: analysis based on 6-hydroxydopamine-induced transmitter release. Brain Res. 1987;435: 258-272.
17. Tribirica E, Feldman J, Bousquet P. Contribution of catecholaminergic neurons of the dorsomedial and ventrolateral medulla oblongata to the hypotensive effect of clonidine in spontaneously hypertensive rats: in vivo voltametric studies. J Hypertens. 1992;10: 1327-1334.
18. Wyss JM, Oparil S, Chen YF. The role of the central nervous system in hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press Publishers: 1990:679-701.
19. Kubo T, Misu Y. Pharmacological characterization of the alpha-adrenoceptors responsible for a decrease of blood pressure in the nucleus tractus solitarii of the rat. Naunyn Schmiedebergs Arch Pharmacol. 1981;317:120-125.
20. Starke K. Regulation of catecholamine release: receptor mediated feedback control in peripheral and central neurons. In: Usdin E, Snyder SH, eds. Frontiers in Catecholamine Research. Oxford, UK: Pergamon Press; 1973:561-565.
21. Langer SZ. Presynaptic regulation of the release of catecholamines. Pharmacol Rev. 1981;32:337-362.
22. Rutledge DR, Cardozo L, Steinberg JD. Racial differences in drug response: isoproterenol effects on heart rate in healthy males. Pharm Res. 1989;6:182-185.
23. Johnson JA, Burlew BS, Stiles RN. Racial differences in beta-adrenoceptor mediated responses. J Cardiovasc Pharmacol. 1995; 25:90-96.
24. Lang CC, Stein CM, Brown RM, Deegan R, Nelson R, He HB, Wood M, Wood AJJ. Attenuation of isoproterenol-mediated vasodilation in blacks. N Engl J Med. 1995;333:155-160.
25. 2, and prostanoid receptor responses. Clin Pharmacol Ther. 1990;47:360-365.
26. 2-adrenoceptors clearly could explain reported differences in basal lymphocyte cAMP production in two ethnic groups. Med Sci Res. 1993;21:313-314.
27. 2-adrenergic receptors. Hypertension. 1995;25: 88-91.
28. Dimsdale JE, Graham RM, Ziegler MG, Zusman RM, Berry CC. Age, race, diagnosis, and sodium effects on the pressor response to infused norepinephrine. Hypertension. 1987;10:564-569.
29. Sherwood A, Hinderliter AL. Responses to alpha- and beta-adrenergic receptor agonists: effects of race in borderline hypertensive compared to normotensive man. Am J Hypertens. 1993;6: 630-635.
30. Eichler HG, Blaschke TF, Huffman BB. Decreased responsiveness of superficial hand veins to phenylephrine in black normotensive males. J Cardiovasc Pharmacol. 1990;16:177-181.
31. 2-stimulation are blunted in chronic heart failure. Clin Pharmacol Ther. 1995;57:142P. Abstract.
32. Stein CM, Deegan R, He HB, Wood AJJ. Beta adrenergic receptor mediated release of norepinephrine in the human forearm. Clin Pharmacol Ther. 1993;54:58-64.
33. Murray S, Davies DS. Bis(trifluoromethyl)aryl derivatives for drug analysis by gas chromatography electron capture negative ion chemical ionization mass spectrometry. Biomedical Mass Spectrometry. 1984;11:435-440.
34. Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol. 1984;247:E21-E28.
35. Wallin BG, Frisk-Holmberg M. The antihypertensive mechanism of clonidine in man: evidence against a generalized reduction of sympathetic activity. Hypertension. 1981;3:340-346.
36. Kooner JS, Birch R, Frankel H, Peart WS, Mathias CJ. Hemodynamic and neurohormonal effects of clonidine in patients with preganglionic and postganglionic sympathetic lesions: evidence for a central sympatholytic action. Circulation. 1991;84:75-83.
37. Ziegler MG, Mills PJ, Dimsdale J. The effect of race on norepinephrine. Life Sci. 1991;49:427-433.
38. Hall D. Pharmacologic therapy of hypertension in blacks. In: Hall WD, Saunders E, Shulman NB, eds. Hypertension in Blacks: Epidemiology, Pathophysiology and Treatment. Chicago, Ill: Year Book Medical Publishers; 1985:182-208.
39. Kaplan NM, Venkatta, C, Ram S. Hypertension in ethnic subgroups. In: Swales JD, ed. Textbook of Hypertension. Oxford, UK: Blackwell Scientific Publications; 1994:811-831.
40. Seedat YK. Varying responses to hypotensive agents in different racial groups: black versus white differences. J Hypertens. 1989;7: 515-518.
41. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Carol F, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG. Single-drug therapy for hypertension in men: comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
42. Bassett DR Jr, Duey WJ, Walker AJ, Howley ET, Bond V. Racial differences in maximal vasodilatory capacity of forearm resistance vessels in normotensive young adults. Am J Hypertens. 1992;5: 781-786.
43. Carlsson I, Sollevi A, Wenmalm A. The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperemia. J Physiol (Lond). 1987;389:147-161.
44. Farmer RJ, Cervenka JH, Stone RA, O'Conner DT. Autonomic function in hypertension: are there racial differences? Circulation. 1990;81:1305-1311.
45. 2-adrenoceptors in man. Circ Res. 1984;54:447-452.